Histidine kinase‐mediated cross‐regulation of the vancomycin‐resistance operon in Clostridioides difficile
Molecular Microbiology · 2024-06 · 121 (6) · 1182-1199
DOI: 10.1111/mmi.15273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Microbiology, 2024-05. Verfasst von Boris R Belitsky. Beteiligte Einrichtung: Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Operon, Clostridioides difficile, Histidine Kinase, Gene Expression Regulation, Bacterial. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
The dipeptide D‐Ala‐D‐Ala is an essential component of peptidoglycan and the target of vancomycin. Most Clostridioides difficile strains possess the vanG operon responsible for the synthesis of D‐Ala‐D‐Ser, which can replace D‐Ala‐D‐Ala in peptidoglycan. The C. difficile vanG operon is regulated by a two‐component system, VanRS, but is not induced sufficiently by vancomycin to confer resistance to this antibiotic. Surprisingly, in the absence of the VanS histidine kinase (HK), the vanG operon is still induced by vancomycin and also by another antibiotic, ramoplanin, in a VanR‐dependent manner. This suggested the cross‐regulation of VanR by another HK or kinases that are activated in the presence of certain lipid II‐targeting antibiotics. We identified these HKs as CD35990 and CD22880. However, mutations in either or both HKs did not affect the regulation of the vanG operon in wild‐type cells suggesting that intact VanS prevents the cross‐activation of VanR by non‐cognate HKs. Overproduction of VanR in the absence of VanS, CD35990, and CD22880 led to high expression of the vanG operon indicating that VanR can potentially utilize at least one more phosphate donor for its activation. Candidate targets of CD35990‐ and CD22880‐mediated regulation in the presence of vancomycin or ramoplanin were identified by RNA‐Seq.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.
ORCID-Profile: Boris R Belitsky
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Belitsky, B. R. (2024). Histidine kinase‐mediated cross‐regulation of the vancomycin‐resistance operon in Clostridioides difficile. Molecular Microbiology, 121(6), 1182-1199. https://doi.org/10.1111/mmi.15273
Vancouver
Belitsky BR. Histidine kinase‐mediated cross‐regulation of the vancomycin‐resistance operon in Clostridioides difficile. Molecular Microbiology. 2024;121(6):1182-1199. doi:10.1111/mmi.15273
BibTeX
@article{Belitsky2024,
author = {Belitsky, Boris R},
title = {Histidine kinase‐mediated cross‐regulation of the vancomycin‐resistance operon in Clostridioides difficile},
journal = {Molecular Microbiology},
year = {2024},
volume = {121},
number = {6},
pages = {1182--1199},
doi = {10.1111/mmi.15273}
}
EUVIMED